Product Information

TOPROL XL 200 MG TABLET is a brand product labeled by Melinta Therapeutics, LLC, priced at $3.3208 per EA under NDC 70842011302. Its NADAC has been published 110 times since Jul 17, 2024.

FDA first approved this application on Jan 10, 1992. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Metoprolol Succinate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

TOPROL XL 200 MG TABLET

Metoprolol Succinate
$3.3208per EA
High Outlier

Strength

200 mg/1

NDC

70842011302

Classification

Brand

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

7/1/2026

Active Ingredients

METOPROLOL SUCCINATE

Approval Type

New Drug (NDA)

FDA Application

NDA019962

FDA Approved

1/10/1992

TE Code

AB

On Market Since

7/3/2023

Pharmacological Classes

Adrenergic beta-Antagonists
beta-Adrenergic Blocker

Price Statistics

The NADAC for TOPROL XL 200 MG TABLET has been published 110 times since Jul 17, 2024, and over the history we have for it it has risen 10.5%. The table below summarizes its recorded NADAC range and movement.

Current price$3.3208 per EA
All-time high$3.3208 (Aug 19, 2026)
All-time low$3.0065 (Jul 17, 2024)
52-week high$3.3208
52-week low$3.1525
Median price$3.1649
Average price$3.1403
Largest weekly change+5.0% (Jan 1, 2025)
Weeks tracked110
Tracking sinceJul 17, 2024

Price History

1W

0.0%

1M

0.0%

3M

+5.1%

6M

+5.3%

1Y

+4.9%

3Y

N/A

5Y

N/A

All

+10.5%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 95% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TOPROL XL 200 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TOPROL XL 200 MG TABLET, manufactured by Melinta Therapeutics, LLC, is $3.3208 per EA (NDC 70842011302), effective Aug 19, 2026.

How has the price of TOPROL XL 200 MG TABLET changed over time?

Over the history we have for it, the NADAC for TOPROL XL 200 MG TABLET has risen 10.5%. It has been tracked across 110 weekly CMS publications since Jul 17, 2024.

What are the highest and lowest recorded NADAC prices for TOPROL XL 200 MG TABLET?

Since Jul 17, 2024, the NADAC for TOPROL XL 200 MG TABLET has ranged from a low of $3.0065 (Jul 17, 2024) to a high of $3.3208 (Aug 19, 2026), with a median of $3.1649 per EA.

Are there cheaper alternatives to TOPROL XL 200 MG TABLET?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METOPROLOL SUCC ER 200 MG TAB, is $0.1678 per EA — about 95% below TOPROL XL 200 MG TABLET.

Who manufactures TOPROL XL 200 MG TABLET?

TOPROL XL 200 MG TABLET (NDC 70842011302) is labeled by Melinta Therapeutics, LLC, and CMS classifies it as a brand product.